Adis Journals
Summary Slide.png (64.55 kB)

Clinical, Ultrasound and Predictability Outcomes following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study

Download (64.55 kB)
posted on 2018-07-17, 14:25 authored by Piercarlo Sarzi-Puttini, Emilio Filippucci, Silvano Adami, Pier Luigi Meroni, Alberto Batticciotto, Luca Idolazzi, Orazio De Lucia, Pablo Talavera, Thomas Kumke, Walter Grassi

Article full text

The full text of this article can be found here.

Provide enhanced content for this article

If you are an author of this publication and would like to provide additional enhanced content for your article then please contact

The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.

Other enhanced features include, but are not limited to:

• Slide decks

• Videos and animations

• Audio abstracts

• Audio slides


UCB Pharma


Usage metrics

    Advances in Therapy


    Ref. manager